Skip to content

Optimization of the treatment of Polycystic ovary syndrome with kidney deficiency and phlegm dampness

Optimization of the treatment of Polycystic ovary syndrome with kidney deficiency and phlegm dampness

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000036470
Enrollment
Unknown
Registered
2020-08-23
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

polycystic ovarian syndrome

Interventions

Sponsors

The First Affiliated Hospital of Naval Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: (1) At the same time, it conforms to the diagnostic criteria of PCOS in Western medicine and the diagnostic criteria of "deficiency of kidney and phlegm-dampness" in TCM; (2) those who have not taken medication or have taken medication but have stopped medication for more than 3 months, and those who have not taken diet and exercise therapy; (3) Volunteer to participate in this clinical study and sign the relevant informed consent.

Exclusion criteria

Exclusion criteria: (1) caused by other reasons and PCOS similar clinical sign and/or endocrine diseases, such as reproductive organs implement qualitative sex pathological change, Cushing's syndrome, theca cell hyperplasia with shaofu zhuyu tang, adrenal cortex hyperplasia, 21 hydroxylase deficiency, the ovaries or adrenal tumors, hyperprolactinemia and abnormal thyroid function, primary diabetes and other metabolic disorder diseases etc. (2) Patients with serious primary diseases such as heart, liver, kidney and hematopoietic system, as well as psychosis; (3) Allergic constitution, allergy to known drugs in this prescription or cause an unpleasant reaction; (4) Incomplete data or inability to judge the efficacy and other factors affecting the efficacy or safety evaluation.

Design outcomes

Primary

MeasureTime frame
ovulation rate;

Secondary

MeasureTime frame
clinical symptoms;TCM symptom;Laboratory tests;

Countries

China

Contacts

Public ContactJin Yu

The First Affiliated Hospital of Naval Medical University

39500545@163.com+86 15821627980

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026